The U.S. Justice Department properly sought dismissal of a whistleblower’s False Claims Act suit alleging a kickback scheme against drugmakers and pharmacy benefit managers including
A district court didn’t err in backing the DOJ’s determination that John R. Borzilleri’s suit accusing the companies of engaging in a fraudulent scheme to overcharge multiple sclerosis drugs under Medicare Part D would be too burdensome on government resources if allowed to continue, the U.S. Court of Appeals for the First Circuit ruled.
In ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.